首页>
外国专利>
GLP-1 gene delivery for the treatment of type 2 diabetes
GLP-1 gene delivery for the treatment of type 2 diabetes
展开▼
机译:GLP-1基因递送用于治疗2型糖尿病
展开▼
页面导航
摘要
著录项
相似文献
摘要
This patent discloses compositions and methods of use thereof to normalize the blood glucose levels of patients with type 2 diabetes. It relates particularly to a plasmid comprising a chicken β actin promoter and enhancer; a modified GLP-1 (7-37) cDNA (pβGLP1), carrying a furin cleavage site, which is constructed and delivered into a cell for the expression of active GLP-1.
展开▼